Accounts Payable - Applied Therapeutics Inc (NASDAQ:APLT) - Alpha Spread

Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 8 USD 1.91% Market Closed
Market Cap: 1B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

Applied Therapeutics Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Applied Therapeutics Inc
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Applied Therapeutics Inc
NASDAQ:APLT
Accounts Payable
$1.7m
CAGR 3-Years
43%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$29.3B
CAGR 3-Years
12%
CAGR 5-Years
21%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
$537m
CAGR 3-Years
-4%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$2.3B
CAGR 3-Years
21%
CAGR 5-Years
18%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$327.9m
CAGR 3-Years
37%
CAGR 5-Years
34%
CAGR 10-Years
20%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$561.7m
CAGR 3-Years
6%
CAGR 5-Years
18%
CAGR 10-Years
28%

See Also

What is Applied Therapeutics Inc's Accounts Payable?
Accounts Payable
1.7m USD

Based on the financial report for Dec 31, 2023, Applied Therapeutics Inc's Accounts Payable amounts to 1.7m USD.

What is Applied Therapeutics Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-10%

Over the last year, the Accounts Payable growth was -61%. The average annual Accounts Payable growth rates for Applied Therapeutics Inc have been 43% over the past three years , -10% over the past five years .

Back to Top